On July 8, Lemonade declined 8.64% in regular trading, trading at $70.97/share, with turnover of $54.03 million.

On the news front, Morgan Stanley downgraded Lemonade from Overweight to Equal Weight, maintaining a $75 price target. The brokerage stated that the company's recent share price rally has largely priced in its growth and earnings outlook, leaving limited room for additional upside without new catalysts.

Morgan Stanley noted that Lemonade's technology-driven growth and underwriting momentum position it well to achieve net income profitability by the end of next year, forecasting gross written premium growth of approximately 35% this year and 30% next year. However, the firm highlighted that competing in a softening auto insurance market while maintaining operating leverage will be key to long-term growth. Notably, Morgan Stanley had upgraded Lemonade to Overweight with an $85 target in March, making this downgrade a reversal reflecting short-term valuation realization pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)